Lehrer S. and Rheinstein P. A derangement of the brain wound healing process may cause some cases of Alzheimer's disease. Discov Med. 2016 Aug;22(119):43-6. HTML pdf

Lehrer S. and Rheinstein P. Relation of Poor Memory to Soluble Tumor Necrosis Factor Receptor Type Two (sTNF-RII). Am J Alzheimers Dis Other Demen. 2015 December pdf

Lehrer S. and Rheinstein P. Two compartment model of MSH/ACTH may be a surrogate for intranasal insulin central nervous system kinetics. Journal of Alzheimer's Disease 31 July 2015. pdf  HTML

Lehrer S. Adverse Side Effects of Intranasal Detemir Insulin in the SNIFF Trial. Journal of Alzheimer's Disease 4 June 2015. pdf  HTML

Lehrer S. and Rheinstein P. Is Alzheimer’s Disease Autoimmune Inflammation of the Brain That Can be Treated With Nasal Nonsteroidal Anti-Inflammatory Drugs? Am J Alzheimers Dis Other Demen.  2015 May;30(3):225-7. pdf

Lehrer S. Nasal NSAIDs for Alzheimer's Disease. Am J Alzheimers Dis Other Demen. 2014 Jan 9;29(5):401-403. pdf

Lehrer S. Inhaled Thyrotropin-Releasing Hormone for Treatment of Neuropsychiatric Disorders. J Clin Psychopharmacol. 2014 Apr;34(2):288-90 pdf

Lehrer S, Rheinstein P, Mulshine J. Inhaled buformin for lymphangioleiomyomatosis and early (airway confined) lung cancer. American Association for Cancer Research Annual Meeting Abstracts 2014;14-A-638-AACR. pdf

Lehrer S. Compositions and Methods of Treating and Preventing Lung Cancer and Lymphangioleiomyomatosis. US Patent 9,248,110, issued February 2, 2016. pdf

Lehrer S. Inhaled Buformin for Lymphangioleiomyomatosis and Lung Cancer: Repurposing an old drug. DIA Presentation. ppt